Stay updated on Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Melanoma Immunotherapy Clinical Trial page
- Check5 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, replacing the expected content. The change reflects an access issue rather than a real update to the study information on the page.SummaryDifference18%

- Check12 days agoChange DetectedThe study locations list was updated to add Tel Litwinsky, Israel, 52621 and remove Qiryat Krinitzi, Israel, 52621.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe recruitment site in Qiry Krinitzi, Israel, 52621 was added, and the Tel Litwinsky, Israel, 52621 site was removed. The document revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision indicator updated from v3.6.4 to v3.6.5 on the study page. This reflects a newer page revision, typically for QC or minor updates.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision indicator was updated to Revision: v3.6.4. This replaces the previous v3.6.3 and reflects a new version of the page.SummaryDifference0.0%

- Check77 days agoChange DetectedNo additions or deletions were provided, and the page content appears unchanged in the given context.SummaryDifference0.0%

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.